Author

N. Pinter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 4 Research Focus:differential expression· 3 Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1

Frequent Co-Authors

O. Schilling· 4 shared M. Cosenza Contreras· 2 shared M. Fahrner· 2 shared P. Bronsert· 2 shared T. Werner· 2 shared A. Grote· 1 shared A. Pagenstecher· 1 shared A. Schaefer· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

O. Schilling

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Proteomic profiling of IDH-wildtype Glioblastoma Tissue and Serum uncovers prognostic Subtypes and Marker Candidates

T. Werner, A. Schaefer, M. Hennes, M. Cosenza Contreras, G. Espadas, E. Sabido, L. Cook, A. Pagenstecher, N. Pinter, T. Feilen, A. Grote, C. Nimsky, J. W. Bartsch, O. Schilling

This study identifies proteomic subtypes and recurrence patterns in IDH-wildtype glioblastoma using tissue and serum samples, revealing prognostic markers and proteomic plasticity in recurrent tumors.

bioRxiv · Feb 29, 2024 · PreprintCancer Biology

Proteomic Characterization of Intrahepatic Cholangiocarcinoma Identifies Distinct Subgroups and Proteins Associated with Time-To-Recurrence

T. Werner, K.-L. Budau, M. Cosenza Contreras, F. Hause, K. Kurowski, N. Pinter, J. Schueler, M. Werner, C. Sigel, L. Tang, P. Bronsert, O. Schilling

This study identifies two proteomic subgroups of intrahepatic cholangiocarcinoma with distinct time-to-recurrence rates and biological processes.

bioRxiv · Feb 28, 2024 · PreprintCancer Biology

Targeted and Explorative Profiling of Kallikrein Proteases and Global Proteome Biology of Pancreatic Ductal Adenocarcinoma, Chronic Pancreatitis, and Normal Pancreas Highlights Disease-Specific Proteome Remodelling

J. Werner, P. Bernhard, M. Cosenza-Contreras, N. Pinter, M. Fahrner, P. Pallavi, J. Eberhard, P. Bronsert, F. Rueckert, O. Schilling

This study profiles kallikrein proteases and global proteomes in PDAC, CP, and normal pancreas, identifying disease-specific proteomic changes and variants.

bioRxiv · Nov 28, 2022Cancer Biology

MaxQuant and MSstats in Galaxy enable reproducible cloud-based analysis of quantitative proteomics experiments for everyone

N. Pinter, D. Glätzer, M. Fahrner, K. Fröhlich, J. Johnson, B. A. Grüning, B. Warscheid, F. Drepper, O. Schilling, M. C. Föll

The paper integrates MaxQuant and MSstats into Galaxy for reproducible cloud-based quantitative proteomics analysis, enabling accessible and transparent workflows for researchers.

bioRxiv · Jan 20, 2022Biochemistry